Metraipolis › archive › dc_a53b35541b15
Efficacy and Safety of Low-Dose Versus Standard-Dose Immunotherapy in Advanced Solid Tumours: A Retrospective Real-World Study From a Resource-Constrained… — Europe PMC PMID:42281727
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42281727
- DOI
- 10.7759/cureus.108640
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T12:55:04.956Z
- SHA-256 of the archived text
e8d52478394316ba200a3a5bb01b8cc3059eef7537e0f57fe2e1b07e9a597379- Stable URL of this page
https://metraipolis.com/documento/dc_a53b35541b15
How to cite
Efficacy and Safety of Low-Dose Versus Standard-Dose Immunotherapy in Advanced Solid Tumours: A Retrospective Real-World Study From a Resource-Constrained… — Europe PMC PMID:42281727 — Europe PMC (en), https://europepmc.org/article/MED/42281727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a53b35541b15 (Metraipolis archive dc_a53b35541b15, sha256 e8d52478394316ba200a3a5bb01b8cc3059eef7537e0f57fe2e1b07e9a597379)
BibTeX
@misc{dca53b35541b15,
title = {Efficacy and Safety of Low-Dose Versus Standard-Dose Immunotherapy in Advanced Solid Tumours: A Retrospective Real-World Study From a Resource-Constrained… — Europe PMC PMID:42281727},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42281727},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a53b35541b15; sha256 e8d52478394316ba200a3a5bb01b8cc3059eef7537e0f57fe2e1b07e9a597379},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42281727. Agents can read the archived copy with the MCP tool read_document.